Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1821
| Despition | NT 4 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 97.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1073 | Dopamine D5 Receptor Blocking Peptide (AC1073) | 250 µg | inquiry |
| ACPP-1718 | Human ASRGL1 Protein (AC1718) | 2 µg | inquiry |
| ACPP-1108 | Recombinant Human CD34 Protein (6×His Tag) (AC1108) | 50 µg | inquiry |
| ACPP-1471 | Human SCG3 Protein (AC1471) | 5 µg | inquiry |
| ACPP-1578 | Human QPCT Protein (AC1578) | 2 µg | inquiry |
| ACPP-1721 | Human QPRT Protein (AC1721) | 5 µg | inquiry |
| ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg | inquiry |
| ACPP-1076 | Synaptophysin Blocking Peptide (AC1076) | 250 µg | inquiry |
| ACPP-1452 | Human HSD17B1 Protein (AC1452) | 2 µg | inquiry |
| ACPP-1266 | ROR1 Blocking Peptide (AC1266) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.